LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.

LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.

Item
http://www.wikidata.org/entity/Q37697180
LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma.Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer.LncRNA FENDRR sensitizes doxorubicin-resistance of osteosarcoma cells through down-regulating ABCB1 and ABCC1.LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.Long non-coding RNA PTENP1 inhibits proliferation and migration of breast cancer cells via AKT and MAPK signaling pathways.The regulatory roles of long non-coding RNAs in the development of chemoresistance in breast cancer.Natural Antisense Transcripts: Molecular Mechanisms and Implications in Breast Cancers.Gene master regulators of papillary and anaplastic thyroid cancers.Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression.Long noncoding RNA DANCR is activated by SALL4 and promotes the proliferation and invasion of gastric cancer cells.The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter.Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer.Deciphering the roles of lncRNAs in breast development and disease.Combined Let-7a and H19 Signature: A Prognostic Index of Progression-Free Survival in Primary Breast Cancer Patients.Long non-coding RNA BRAF-regulated lncRNA 1 promotes lymph node invasion, metastasis and proliferation, and predicts poor prognosis in breast cancer.Long Non-Coding RNAs as New Master Regulators of Resistance to Systemic Treatments in Breast CancerThe N-terminal polypeptide derived from vMIP-II exerts its anti-tumor activity in human breast cancer by regulating lncRNA SPRY4-IT1
P2860

LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.

Item
http://www.wikidata.org/entity/Q37697180
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@en
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@nl
type
label
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@en
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@nl
prefLabel
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@en
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
LncRNA H19 confers chemoresist ...... of the pro-apoptotic gene BIK.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932